Suppr超能文献

D-二聚体对扩张型心肌病预后的价值:一项回顾性队列研究。

The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study.

机构信息

Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.

出版信息

Sci Rep. 2024 Nov 5;14(1):26806. doi: 10.1038/s41598-024-76716-z.

Abstract

D-dimer is a biomarker of coagulation and fibrinolytic system activation in response to the hypercoagulable state of the body. The research aimed to analyze the value of D-dimer in the prognosis of patients with dilated cardiomyopathy (DCM). Patients admitted to our center for the first time with DCM were enrolled consecutively. The clinical characteristics variables were obtained from the electronic medical record system, and the prognostic information was obtained using telephone return visits and a review of repeated hospitalization records. Univariate and multivariate Cox regression was used to explore the association of D-dimer with all-cause mortality. Smooth curve fitting, threshold saturation effect analysis, and subgroup analysis were performed. Ultimately, 534 patients were included. After a follow-up of the enrolled patients, 485 patients obtained prognostic information, of which 159 died from all causes, and the main cause of death was heart failure (89/159), the sudden death accounted for about 17%. The independent positive association between D-dimer and all-cause mortality remained unchanged in both unadjusted and adjusted Cox regression models. In the fully adjusted model, each standard deviation increase in D-dimer was associated with a 14% increase in all-cause mortality (HR = 1.14; 95% CI: 1.02 ~ 1.27; P < 0.05). Curve fitting and threshold effect analysis showed an inflection point in the relationship between D-dimer and all-cause mortality (non-linear test: P = 0.03). When D-dimer was equal to 362ng/ml, HR = 1; and as the value increased, the risk of all-cause mortality increased by 34.7% for every 2-fold increase in D-dimer gradually (HR = 1.347; 95% CI: 1.069 ~ 1.697; P = 0.012). In subgroup analysis, D-dimer and BMI had a significant interaction on all-cause mortality, with a significantly increased risk of all-cause mortality in subjects with BMI ≥ 25 kg/m (HR = 1.99; 95% CI: 1.34 ~ 2.97; P < 0.01). The ROC curve showed that D-dimer was a good predictor of all-cause mortality, and the areas under the curve at 1-, 3-, and 5-year were 0.71, 0.64, and 0.59, respectively. In addition, D-dimer improved the predictive performance of the MAGGIC heart failure score in patients with DCM. D-dimer is not only independently associated with all-cause mortality in DCM patients, but also has good predictive value, suggesting that D-dimer may be an early and useful marker for improving the management of DCM patients.

摘要

D-二聚体是凝血和纤维蛋白溶解系统激活的生物标志物,反映了机体的高凝状态。本研究旨在分析 D-二聚体对扩张型心肌病(DCM)患者预后的价值。连续纳入首次因 DCM 入住我院的患者。从电子病历系统中获取临床特征变量,通过电话随访和重复住院记录回顾获取预后信息。采用单因素和多因素 Cox 回归分析 D-二聚体与全因死亡率的相关性。进行平滑曲线拟合、阈值饱和效应分析和亚组分析。最终纳入 534 例患者。对入组患者进行随访后,485 例患者获得了预后信息,其中 159 例死于各种原因,主要死因是心力衰竭(89/159),猝死约占 17%。D-二聚体与全因死亡率之间的独立正相关关系在未调整和调整后的 Cox 回归模型中均保持不变。在完全调整的模型中,D-二聚体每增加一个标准差,全因死亡率增加 14%(HR=1.14;95%CI:1.021.27;P<0.05)。曲线拟合和阈值效应分析显示 D-二聚体与全因死亡率之间存在拐点(非线性检验:P=0.03)。当 D-二聚体等于 362ng/ml 时,HR=1;随着 D-二聚体值的升高,D-二聚体每增加 2 倍,全因死亡率的风险增加 34.7%(HR=1.347;95%CI:1.0691.697;P=0.012)。在亚组分析中,D-二聚体与 BMI 对全因死亡率有显著的交互作用,BMI≥25kg/m 的患者全因死亡率的风险显著增加(HR=1.99;95%CI:1.34~2.97;P<0.01)。ROC 曲线显示 D-二聚体是全因死亡率的良好预测指标,其在 1、3、5 年的曲线下面积分别为 0.71、0.64 和 0.59。此外,D-二聚体提高了 MAGGIC 心力衰竭评分在 DCM 患者中的预测性能。D-二聚体不仅与 DCM 患者的全因死亡率独立相关,而且具有良好的预测价值,提示 D-二聚体可能是改善 DCM 患者管理的早期有用标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88b7/11538493/512d55dd0ab8/41598_2024_76716_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验